Analystreport

Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) is now covered by analysts at Evercore ISI. They set a $8.42 price target on the stock.

Dicerna Pharmaceuticals, Inc.  (DRNA) 
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dicerna.com